{
    "title": "Liverpool is starting universal supplementation and needs high dose vitamin D",
    "slug": "liverpool-is-starting-universal-supplementation-and-needs-high-dose-vitamin-d",
    "aliases": [
        "/Liverpool+is+starting+universal+supplementation+and+needs+high+dose+vitamin+D+\u2013+March+2014",
        "/5086"
    ],
    "tiki_page_id": 5086,
    "date": "2014-02-24",
    "categories": [
        "Europe"
    ],
    "tags": [
        "CKD",
        "Europe",
        "bacteria",
        "blood levels",
        "bone",
        "bone cancer",
        "breastfed",
        "breathing",
        "cancer",
        "child",
        "childhood cancer",
        "childhood obesity",
        "cystic fibrosis",
        "diabetes",
        "dosage",
        "falls fractures",
        "growing pains",
        "headache",
        "health risk",
        "high dose",
        "hypertension",
        "kidney",
        "lymphoma",
        "metabolic",
        "obesity",
        "obesity and cancer",
        "osteoporosis",
        "pain",
        "pregnancy",
        "rickets",
        "therapeutic intervention",
        "tuberculosis",
        "type 1 diabetes",
        "vitamin d",
        "vitamin d blood test",
        "weight loss"
    ]
}


## Vitamin D testing: three important issues (letter)

British Journal of General Practice March 1, 2014 vol. 64 no. 620 124 

Katy Gardner: GP and Clinical Lead for Vitamin D, Liverpool, UK.  katyagardner@btinternet.com

Stephen Zhao: Rheumatology trainee Aintree University Hospital, Liverpool, UK.

In Liverpool we are auditing vitamin D testing and prescribing in primary care, following guidelines issued to GPs in early 2012 to encourage evidenced based testing and prescribing.1 Our data indicates that some GPs are testing in an increasingly non-targeted way. GPs in Liverpool ordered over £100 000 worth of vitamin D tests in 2012, over 10 times the amount spent in 2007. Though more people were identified as deficient, the proportion of deficient results identified decreased significantly. We feel guidance from NICE is needed for detection and treatment of vitamin D deficiency in primary care.

We also feel it is  **high time for universal vitamin D supplementation of pregnant and postnatal women and young children**  as recommended by Chief Medical Officers.2 With our increasingly diverse population in the UK we are very aware that currently some groups are missing out on prevention, and Healthy Start vitamin uptake is very low.  **In Liverpool we are rolling out universal supplementation out this spring** . This should lead to a decrease in vitamin D deficiency, decrease in rickets and decrease in need for testing and high dose prescribing.

Thirdly and very importantly the authors wonder why the use of licensed preparations is so low in primary care. This is because there are no high-dose licensed preparations available for us to prescribe. I have been working with vitamin D deficient patients for the past 10 years. My experience, as well as that of GP colleagues up and down the country, is that  **compliance is a big problem with low dose preparations**  particularly in certain population groups at risk of deficiency. 

Liverpool has a substantial Somali population with deficiency identified in around 80% of individuals.3 Our experience is that to ensure compliance with treatment in our Somali population we need to give a high loading dose of vitamin D over a short period of time. There is also no high-dose licensed liquid preparation for children. I note the authors appear to have had some connections with various pharmaceutical companies involved in vitamin D manufacture. It would be excellent to see some high dose preparations licensed for use in the UK.

## REFERENCES

* 1.↵ Gardner K (2012) Mersey Cluster — Guidance for Vitamin D Deficiency and Treatment Options. http://www.northmerseyammc.nhs.uk/Library/publications/North%20Mersey%20Guidance%20for%20Vitamin%20D%20Deficiency%20FINAL%20VERSION%20feb12.pdf (accessed 5 Feb 2014).  **PDF is attached at the bottom of this page and extracted below** 

* 2.↵ Vitamin D — advice on supplements for at risk groups (February, 2012) (Department of Health),

> https://www.gov.uk/government/publications/vitamin-d-advice-on-supplements-for-at-risk-groups (accessed 5 Feb 2014).

* 3.↵ Bunn J, Gardner K, Vitlani K, et al. North West Public Health Conference (17 Sept 2013, Manchester), Vitamin D deficiency in Liverpool Somalis: a significant problem. <span>[abstract]</span>. Search Google Scholar

---

## [Leeds (UK) councillors worried about rickets](http://www.yorkshirepost.co.uk/news/main-topics/politics/leeds-councillors-worried-about-rickets-1-6459682) Feb 2014

* The Lib Dem group on Leeds City Council wants funding for  **free**  vitamin supplements for children under four.

* The Lib Dems will propose an amendment which would see £430,000 of public health money spent on vitamins for children when the council budget is debated tomorrow.

---

## See also VitaminDWiki

* [Rickets in England – huge recent increase – Feb 2014](/posts/rickets-in-england-huge-recent-increase)

* [Why the UK government ignores evidence for the benefits of Vitamin D - Nov 2013](/posts/why-the-uk-government-ignores-evidence-for-the-benefits-of-vitamin-d)

* [Presentation: pre and post natal vitamin D, with audience comments – Manchester UK Sept 2013](/posts/presentation-pre-and-post-natal-vitamin-d-with-audience-comments-manchester-uk)

* [National Osteoporosis Society of UK declares that 12 ng of vitamin D is enough – June 2013](/posts/national-osteoporosis-society-of-uk-declares-that-12-ng-of-vitamin-d-is-enough)

* [Vitamin D conference in England - April 23-25 2014](/posts/vitamin-d-conference-in-england-april-23-25-2014)

* [Vitamin D – The Sunshine Vitamin Most Indoor Workers Are Lacking – Gillie May 2013](/posts/vitamin-d-the-sunshine-vitamin-most-indoor-workers-are-lacking-gillie)

* [Overview of Rickets and Vitamin D](/posts/overview-of-rickets-and-vitamin-d)

---

## Extract from Liverpool PDF

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"

"http://www.w3.org/TR/html4/loose.dtd">

<html>

<head><meta http-equiv="content-type" content="text/html; charset=WINDOWS-1252"/><meta name="generator" content="MSG_EXP_HTML_FINE_READER_TRADE_MARK"/><meta name="author" content="walshv"/><title>Microsoft Word - North Mersey Guidance for Vitamin D Deficiency FINAL VERSION feb12</title><link rel="stylesheet" href="Liverpool Feb 2014.css" type="text/css"/>

</head>

<body>

<p style="background-color:#FFFFFF;text-align:center;padding:0pt 0pt 15pt 0pt;"><a name="bookmark0"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Mersey Cluster - Guidance for Vitamin D Deficiency and Treatment Options</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:15pt 7pt 12pt 7pt;"><span class="font1">Recent BMJ articles<sup>1,2</sup> highlighted the problem of vitamin D deficiency in the UK population. There is an increasing body of evidence associating such deficiency with an increased risk of morbidity not only due to bone/muscle disorders but a variety of other conditions<sup>3</sup>. Prescribers may encounter patients whose clinical presentation is either principally due to vitamin D deficiency or is complicated by its presence. A recent letter was sent to all healthcare professionals from the Chief Medical Officer highlighting the risk of Vitamin D deficiency. +</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 7pt 12pt 7pt;"><span class="font1">Consensus suggests Vitamin D is mainly obtained by the action of UV rays on our skin. A US study<sup>4</sup> suggests 5-15 minutes (longer for darker skin) daily sun exposure between 10am and 3pm from April to October would be sufficient to improve vitamin D status<sup>5</sup>. Dietary sources of Vitamin D include oily fish, egg yolk, fortified foods e.g. cereal and margarine<sup>6</sup>.</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 0pt 15pt 7pt;"><span class="font1">Please see national advice leaflet at:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:15pt 0pt 15pt 7pt;"><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.dh.gov.uk/health/2012/02/advice-vitamin-d/">http://www.dh.gov.uk/health/2012/02/advice-vitamin-d/</a></span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:15pt 7pt 12pt 7pt;"><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.dh.gov.uk/prod">http://www.dh.gov.uk/prod</a> consum dh/groups/dh digitalassets/@dh/@en/documents/digitalas set/dh 132508.pdf</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 0pt 15pt 7pt;"><span class="font1">or Map of Medicines </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://eng.mapofmedicine.com/evidence/map/index.html">http://eng.mapofmedicine.com/evidence/map/index.html</a></span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:15pt 7pt 12pt 7pt;"><span class="font1">There is a lack of consensus regarding the precise definition of vitamin D deficiency. Some authorities recommend treatment below 25nmol/L while others recommend 50nmol/L. The Liverpool criteria for deficiency (Total 25 (OH)D concentration) is &lt;30 nmol/L and for insufficiency &gt;30-50 nmol/L. This may vary across North Mersey.</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 7pt 0pt 7pt;"><span class="font1" style="font-style:italic;">The scope of this guidance is to review the treatment and prevention of Vitamin D deficiency, please see Appendix 1 for further information and advice regarding care of patients who fall outside the scope of this guidance including those with osteoporosis and eGFR &lt;30 mL/minute/1.73m<sup>2</sup></span></p>

<table>

<tr><td>

<table border="1">

<tr><td colspan="4" style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="text-align:center;padding:0pt 0pt 3pt 0pt;"><span class="font1" style="font-weight:bold;">Table 1: Liverpool Definition of Vitamin D status reported as Serum 25-Hydroxyvitamin D</span></p>

<p style="text-align:center;padding:3pt 0pt 0pt 0pt;"><span class="font1" style="font-weight:bold;">[25(OH)D] Total Concentrations</span></p></td></tr>

<tr><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">nmol/L*</span></p></td><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">ng/mL*</span></p></td><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Vitamin D Status</span></p></td><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="text-align:justify;padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Health status</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&lt;30</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&lt;12</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Deficiency</span></p></td><td style="background-color:#FFFFFF;">

<p style="text-align:justify;padding:0pt 7pt 0pt 6pt;"><span class="font1">Associated with vitamin D deficiency, leading to rickets in infants and children and osteomalacia in adults</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&gt;30-50</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">12-20</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Insufficiency</span></p></td><td style="background-color:#FFFFFF;">

<p style="text-align:justify;padding:0pt 7pt 0pt 6pt;"><span class="font1">Generally considered inadequate for bone and overall health in healthy individuals</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&gt;50</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&gt;20</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Adequate</span></p></td><td style="background-color:#FFFFFF;">

<p style="text-align:center;"><span class="font1">Generally considered adequate for bone and overall health in healthy individuals. ***Remember levels may decrease over autumn/winter***</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&gt;75</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">&gt;30</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Optimal</span></p></td><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="text-align:justify;padding:0pt 7pt 0pt 6pt;"><span class="font1">Emerging evidence links potential adverse effects to high concentrations particularly &gt;150 nmol/L (&gt;60 ng/mL)</span></p></td></tr>

</table></td></tr>

<tr><td>

<p style="background-color:#FFFFFF;"><span class="font1" style="font-weight:bold;">Please Note:</span><span class="font1"> Serum concentrations of 25(OH)D reported in either nanomoles per litre (nmol/L)</span></p>

<p style="background-color:#FFFFFF;"><span class="font1">or nanograms per millilitre (ng/mL). 1ng/mL = 2.5nmol/L</span></p>

<p style="background-color:#FFFFFF;"><span class="font1">Since 2010 clinical chemistry laboratories should be reporting results in nmol/L.</span></p></td></tr>

</table>

<p style="background-color:#FFFFFF;padding:0pt 0pt 15pt 17pt;"><span class="font1" style="font-weight:bold;font-style:italic;text-decoration:underline;">Who should be tested?</span></p>

<p style="background-color:#FFFFFF;padding:15pt 0pt 15pt 17pt;"><span class="font1" style="font-weight:bold;">Routine testing of Vitamin D levels is NOT recommended.</span></p>

<p style="background-color:#FFFFFF;padding:15pt 0pt 15pt 17pt;"><span class="font1" style="font-weight:bold;font-style:italic;">Assessing the patient:</span></p>

<p style="background-color:#FFFFFF;padding:15pt 43pt 12pt 1pt;"><span class="font1" style="font-weight:bold;">If patient is healthy with no risk factors and is symptom free</span><span class="font1"> - NO investigations are required. Offer lifestyle advice and consider over the counter preventative therapies.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 14pt 12pt 1pt;"><span class="font1" style="font-weight:bold;">If a patient presents with risks factors only -</span><span class="font1"> Offer lifestyle advice and consider long term preventative therapies</span></p>

<p style="background-color:#FFFFFF;padding:12pt 14pt 6pt 1pt;"><span class="font1" style="font-weight:bold;">If a patient presents with risk factors </span><span class="font1" style="font-weight:bold;text-decoration:underline;">and</span><span class="font1" style="font-weight:bold;"> signs and symptoms</span><span class="font1"> - Vitamin D deficiency should be considered. Vitamin D levels should be measured</span><span class="font1" style="font-weight:bold;font-style:italic;"> ONLY</span><span class="font1"> if patients are symptomatic </span><span class="font1" style="font-weight:bold;">AND</span><span class="font1"> have other risk factors unless clinically appropriate.</span></p>

<p style="background-color:#FFFFFF;padding:6pt 0pt 0pt 17pt;"><span class="font1" style="font-weight:bold;">Risk factors for vitamin D deficiency include:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Black &amp; ethnic minority patients with darker skin</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Elderly patients in residential care, housebound or institutionalised patients</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Older people aged 65 years and over</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Infants and young children under 5 years of age</span></p>

<p style="background-color:#FFFFFF;padding:0pt 14pt 0pt 17pt;"><span class="font1">• Intestinal malabsorption e.g. coeliac disease, crohns disease, gastrectomy, cholestatic liver disease</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Routine covering of face or body e.g. habitual sunscreen use factor 15 or above</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Vegan/vegetarian diet</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Liver or renal disease</span></p>

<p style="background-color:#FFFFFF;padding:0pt 14pt 0pt 17pt;"><span class="font1">• Medications including certain anticonvulsants, cholestyramine, colestipol, liquid paraffin, sucralfate, rifampicin, glucocorticoids, highly active antiretrovirals</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Obesity (BMI &gt;30)</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• All pregnant and breast feeding women, especially teenagers and young women</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Short interval pregnancies</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Patients with persistently low calcium, low phosphate or raised Alkaline Phosphatase</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Low vitamin D dietary intake</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Cystic fibrosis</span></p>

<p style="background-color:#FFFFFF;padding:0pt 14pt 12pt 17pt;"><span class="font1">• If one family member is Vitamin D deficient it is likely others in the family may also be deficient, unless that person has a specific medical condition</span></p>

<p style="background-color:#FFFFFF;text-align:center;padding:12pt 0pt 0pt 5pt;"><a name="bookmark1"></a><span class="font1" style="font-weight:bold;">AND</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><a name="bookmark2"></a><span class="font1" style="font-weight:bold;">Signs/symptoms include:</span></p>

<p style="background-color:#FFFFFF;padding:0pt 14pt 0pt 17pt;"><span class="font1">• Young children or infants can present with bony deformity (rickets), irritability, reluctance to weight bear, impaired growth and even neonatal tetany</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Older children may present with lethargy and general aches &amp; pains e.g. growing pains<sup>7,8</sup></span></p>

<p style="background-color:#FFFFFF;padding:0pt 14pt 6pt 17pt;"><span class="font1">• Adults often present with generalised musculoskeletal and or bone pain, muscle weakness and lethargy</span></p>

<p style="background-color:#FFFFFF;text-align:center;padding:6pt 0pt 5pt 5pt;"><a name="bookmark3"></a><span class="font1" style="font-weight:bold;">Only test if both risk factors and symptoms are present or if clinically appropriate</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:54pt 0pt 0pt 1pt;"><a name="bookmark4"></a><span class="font1" style="font-weight:bold;font-style:italic;text-decoration:underline;">Investigations:</span></p>

<p style="background-color:#FFFFFF;padding:0pt 19pt 0pt 1pt;"><span class="font1" style="font-weight:bold;">If the patient has both risk factors and symptoms the following investigations should be carried out:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 3pt 1pt;"><span class="font1">• Serum 25-hydroxyvitamin D (25(OH)D)</span></p>

<p style="background-color:#FFFFFF;padding:3pt 19pt 0pt 15pt;"><span class="font1">• Serum Calcium - to exclude hypercalcaemia and obtain baseline for monitoring. If low vitamin D confirmed and calcium result is raised or high-normal, check parathyroid hormone. Do not check parathyroid hormone routinely</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Alkaline Phosphatase and Phosphate</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 1pt;"><span class="font1">• Liver and renal function</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 12pt 1pt;"><span class="font1">• Full blood count (there may be coexisting anaemia if dietary factors are involved)</span></p>

<p style="background-color:#FFFFFF;padding:12pt 34pt 12pt 1pt;"><span class="font1">If there is a history of confirmed Vitamin D deficiency and anaemia ensure ongoing advice is provided to reduce associated risks.</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 0pt 15pt 1pt;"><span class="font1" style="font-weight:bold;text-decoration:underline;">Diagnosis and coding</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:15pt 0pt 57pt 1pt;"><span class="font1">NB If deficiency diagnosed use the Read code</span><span class="font1" style="font-weight:bold;"> .C28 Vitamin D deficiency</span><span class="font1"> (for audit purposes)</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:57pt 12pt 0pt 1pt;"><span class="font1" style="font-weight:bold;">All patients at risk of Vitamin D deficiency require ongoing lifestyle advice regarding sunlight exposure and diet. See Liverpool Patient leaflet for further information available at Map of Medicines</span><span class="font1"> </span><span class="font1" style="text-decoration:underline;"><a href="http://eng.mapofmedicine.com/evidence/map/index.html">http://eng.mapofmedicine.com/evidence/map/index.html</span><span class="font1" style="font-weight:bold;"></a> or </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.northmerseyammc.nhs.uk/">www.northmerseyammc.nhs.uk/</a></span></p>

<table border="1">

<tr><td colspan="3" style="background-color:#E0E0E0;">

<p style="text-align:center;padding:0pt 3pt 0pt 0pt;"><span class="font2" style="font-weight:bold;">Table 2: Vitamin D treatment guidelines.</span></p></td></tr>

<tr><td colspan="3" style="background-color:#E0E0E0;">

<p style="text-align:center;padding:0pt 3pt 0pt 0pt;"><span class="font1" style="font-weight:bold;">Exclude patients with hypercalcaemia or an eGFR &lt;30mL/minute/1.73m<sup>2</sup>. See Appendix 1</span></p></td></tr>

<tr><td style="background-color:#E0E0E0;">

<p style="text-align:center;padding:0pt 3pt 0pt 0pt;"><span class="font1" style="font-weight:bold;">Patient Characteristics</span></p></td><td style="vertical-align:middle;background-color:#E0E0E0;">

<p style="text-align:center;padding:0pt 0pt 0pt 5pt;"><span class="font1" style="font-weight:bold;">Recommendations</span></p></td><td style="vertical-align:middle;background-color:#E0E0E0;">

<p style="text-align:center;"><span class="font1" style="font-weight:bold;">Notes</span></p></td></tr>

<tr><td style="vertical-align:middle;background-color:#FFFFFF;">

<p style="text-align:center;padding:0pt 3pt 15pt 0pt;"><span class="font1" style="font-weight:bold;">Deficiency in adults:</span></p>

<p style="padding:15pt 50pt 12pt 10pt;"><span class="font1" style="font-weight:bold;">&lt;30nmol/L Or &lt;12ng/mL</span></p>

<p style="padding:12pt 23pt 39pt 10pt;"><span class="font1" style="font-weight:bold;">Deficiency:</span><span class="font1"> high dose treatment initially, then long term maintenance treatment required</span></p>

<p style="padding:39pt 9pt 0pt 10pt;"><span class="font1" style="font-weight:bold;">If deficiency is diagnosed in pregnancy please follow guidelines of your local maternity services provider</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 12pt 0pt 6pt;"><span class="font1">Most UK Guidelines suggest a loading dose of 300,000IU colecalciferol is required to replenish Vitamin D concentration.</span></p>

<p style="padding:0pt 12pt 33pt 6pt;"><span class="font1">Various regimes can be considered to achieve this.</span></p>

<p style="text-align:center;padding:33pt 0pt 0pt 5pt;"><span class="font1" style="font-style:italic;">Check Vitamin D concentration</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">after 6 months to ensure</span></p>

<p style="text-align:center;padding:0pt 0pt 0pt 5pt;"><span class="font1" style="font-style:italic;">adequate replacement and/or</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">concordance.</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">If &gt;100nmol/L consider</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">reducing dose.</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">If still deficient alter dose as</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">necessary.</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">If sufficient no further</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-style:italic;">monitoring recommended</span></p></td><td style="vertical-align:middle;background-color:#FFFFFF;">

<p style="padding:0pt 0pt 3pt 6pt;"><span class="font1" style="font-weight:bold;">Treatment Dose:</span></p>

<p style="padding:3pt 16pt 6pt 6pt;"><span class="font1">Due to compliance issues locally Liverpool are suggesting a loading dose is given by either:</span></p>

<p style="padding:6pt 16pt 6pt 6pt;"><span class="font1">Colecalciferol 20,000IU orally ONE daily for 15 days</span></p>

<p style="text-align:center;padding:6pt 0pt 12pt 0pt;"><span class="font1">OR</span></p>

<p style="text-align:center;padding:12pt 0pt 12pt 0pt;"><span class="font1">Colecalciferol 20,000IU orally FIVE daily for 3 days</span></p>

<p style="padding:12pt 0pt 12pt 6pt;"><span class="font1" style="font-weight:bold;">Maintenance dose:</span></p>

<p style="padding:12pt 16pt 6pt 6pt;"><span class="font1">Colecalciferol 20,000 IU ONE orally once a month</span></p>

<p style="padding:6pt 16pt 0pt 6pt;"><span class="font3" style="font-style:italic;">Prescribers can prescribe from a selection of available products to give a total dose as recommended above. See Appendix 2 for further prescribing and product information</span></p></td></tr>

<tr><td colspan="3" style="background-color:#C1C1C1;">

<p style="text-align:center;"><span class="font1" style="font-weight:bold;">Alfacalcidol is not considered appropriate for community use in Vitamin D deficiency unless advised by specialists due to the risk of hypercalcaemia. See Appendix 3</span></p></td></tr>

</table>

<table border="1">

<tr><td colspan="3" style="background-color:#C1C1C1;">

<p style="text-align:center;"><span class="font2" style="font-weight:bold;">Table 2: Vitamin D treatment guidelines.</span></p></td></tr>

<tr><td style="vertical-align:bottom;background-color:#C1C1C1;">

<p style="padding:0pt 0pt 3pt 6pt;"><span class="font1" style="font-weight:bold;">Patient</span></p>

<p style="padding:3pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Characteristics</span></p></td><td style="vertical-align:middle;background-color:#C1C1C1;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Recommendations</span></p></td><td style="vertical-align:middle;background-color:#C1C1C1;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Notes</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 32pt 12pt 6pt;"><span class="font1" style="font-weight:bold;">Insufficiency in adults:</span></p>

<p style="padding:12pt 32pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">&gt;30 to 50nmol/L Or</span></p>

<p style="padding:0pt 0pt 15pt 6pt;"><span class="font1" style="font-weight:bold;">&gt;12-20ng/mL</span></p>

<p style="padding:15pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Insufficiency:</span></p>

<p style="padding:0pt 9pt 0pt 6pt;"><span class="font1">Maintenance treatment likely to be required</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 30pt 9pt 6pt;"><span class="font1">There is currently a lack of evidence on the functional outcomes of populations with insufficient vitamin D concentration to justify the treatment of all patients with insufficiency.</span></p>

<p style="padding:9pt 9pt 0pt 6pt;"><span class="font1">Assess patient holistically Consider prescribing if symptomatic &amp; at risk / previously deficient/ unlikely to take supplements / breast feeding or considering pregnancy / wintertime</span></p></td><td style="vertical-align:bottom;background-color:#FFFFFF;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Maintenance dose:</span></p>

<p style="padding:0pt 17pt 0pt 24pt;"><span class="font1">• Vitamin D equivalent to 800IU daily e.g. Vitamin D 400IU (10mcg) tablets. One tablet twice daily for life.</span></p>

<p style="padding:0pt 9pt 0pt 42pt;"><span class="font1">• A range of Vitamin D tablets are available to buy from community pharmacies, health food stores or via prescription. (See Appendix 2)</span></p>

<p style="padding:0pt 9pt 0pt 42pt;"><span class="font1">• Calcium and Vitamin D tablets e.g Calcichew D3 Forte and Adcal D3 are licensed preparations available on prescription and can be considered for maintenance treatment</span></p>

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1">Or where compliance may be an issue</span></p>

<p style="padding:0pt 17pt 0pt 24pt;"><span class="font1">• Colecalciferol 20,000IU one capsule per month available via prescription</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 9pt 12pt 6pt;"><span class="font1" style="font-weight:bold;">Healthy or at risk adults</span></p>

<p style="padding:12pt 9pt 12pt 6pt;"><span class="font1" style="font-weight:bold;">&gt;50-75nmol/L Or &gt; 20ng/mL</span></p>

<p style="padding:12pt 0pt 0pt 6pt;"><span class="font1">Symptom free</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 0pt 15pt 6pt;"><span class="font1">Lifestyle advice</span></p>

<p style="padding:15pt 9pt 0pt 6pt;"><span class="font1">Can consider daily self treatment with over the counter purchased supplement of 400-800IU Vitamin D daily</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 9pt 12pt 6pt;"><span class="font1">Over the counter products contain amounts likely to prevent rickets/osteomalacia, but are unlikely to raise Vitamin D concentration to optimal in most people who are deficient.</span></p>

<p style="padding:12pt 9pt 0pt 6pt;"><span class="font1">NB prevention may be needed in older people / housebound / in institution</span></p></td></tr>

<tr><td style="background-color:#C1C1C1;">

<p style="padding:0pt 0pt 3pt 6pt;"><span class="font1" style="font-weight:bold;">Patient</span></p>

<p style="padding:3pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Characteristics</span></p></td><td style="vertical-align:middle;background-color:#C1C1C1;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Recommendations</span></p></td><td style="vertical-align:middle;background-color:#C1C1C1;">

<p style="padding:0pt 0pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Notes</span></p></td></tr>

<tr><td style="background-color:#FFFFFF;">

<p style="padding:0pt 9pt 0pt 6pt;"><span class="font1" style="font-weight:bold;">Prevention in children</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 9pt 6pt 6pt;"><span class="font1" style="font-style:italic;">COMA<sup>9</sup> (Committee on Medical aspects of food) recommends:</span></p>

<p style="padding:6pt 9pt 6pt 6pt;"><span class="font1">All infants except those taking at least 500ml of infant formula have a total of 280-340iu Vitamin D daily for the first four years of life.</span></p>

<p style="padding:6pt 9pt 6pt 6pt;"><span class="font1">Fully breast fed infants: see prevention in pregnancy</span></p>

<p style="padding:6pt 9pt 0pt 6pt;"><span class="font1">At risk children supplemented up to the age of five years.</span></p>

<p style="padding:0pt 9pt 6pt 6pt;"><span class="font1">This can be achieved with Healthy Start vitamins.</span></p>

<p style="padding:6pt 9pt 0pt 6pt;"><span class="font1">Alternatives are Abidec and Dalivit drops (Vitamin A, B group, C and D) for children -available to buy or through GP</span></p></td><td style="background-color:#FFFFFF;">

<p style="padding:0pt 9pt 6pt 6pt;"><span class="font1">Healthy Start Children's Vitamin drops (Vitamin A 5000units, Vitamin D 2000units and ascorbic acid 150mg/ml)</span></p>

<p style="padding:6pt 0pt 3pt 6pt;"><span class="font1">Recommended dose:</span></p>

<p style="padding:3pt 9pt 12pt 6pt;"><span class="font1">Child 1 month - 5years: 5 drops daily (5 drops contain approximately 700units Vitamin A, 300units Vitamin D, 20mg Ascorbic Acid; BNF 62 page 627)</span></p>

<p style="padding:12pt 9pt 0pt 6pt;"><span class="font1">Healthy Start vitamins are usually available with vouchers through Children's Centres and many Health Centres. Only Healthy Start beneficiaries can access vouchers. However Healthy Start may be universally available in some parts of the Mersey Cluster.</span></p>

<p style="padding:0pt 9pt 0pt 6pt;"><span class="font1">See Appendix 4 for further information regarding this scheme or visit <a href="http://www.healthystart.nhs.uk/">http://www.healthystart.nhs.uk/</a> or discuss with your health visitor / midwife</span></p></td></tr>

</table>

<p style="background-color:#C1C1C1;"><a name="bookmark5"></a><span class="font2" style="font-weight:bold;">Table 2: Vitamin D treatment guidelines.</span></p>

<p style="background-color:#C1C1C1;padding:0pt 0pt 3pt 0pt;"><span class="font1" style="font-weight:bold;">Patient</span></p>

<p style="background-color:#C1C1C1;padding:3pt 0pt 0pt 0pt;"><span class="font1" style="font-weight:bold;">Characteristics</span></p><div style="float:right;layout-flow:horizontal;">

<p style="background-color:#C1C1C1;padding:0pt 0pt 0pt 5pt;"><span class="font1" style="font-weight:bold;">Recommendations</span></p></div><div style="float:right;layout-flow:horizontal;">

<p style="background-color:#C1C1C1;padding:0pt 0pt 0pt 5pt;"><span class="font1" style="font-weight:bold;">Notes</span></p></div>

<table cellpadding="5pt">

<tr>

<td valign="top" width="21%">

<p style="background-color:#FFFFFF;padding:0pt 29pt 102pt 1pt;"><span class="font1" style="font-weight:bold;">Prevention in Pregnancy and Breastfeeding</span></p>

<p style="background-color:#FFFFFF;padding:102pt 0pt 0pt 1pt;"><span class="font1" style="font-weight:bold;">If deficiency is diagnosed in pregnancy please follow guidelines of local maternity services provider</span></p></td>

<td valign="top" width="34%">

<p style="background-color:#FFFFFF;padding:0pt 2pt 12pt 1pt;"><span class="font1">COMA<sup>9</sup> (Committee on Medical Aspects of food) recommends: All pregnant and lactating women have a total of 400iu Vitamin D/day</span></p>

<p style="background-color:#FFFFFF;padding:12pt 2pt 12pt 1pt;"><span class="font1">Pregnant women suspected of being vitamin D deficient should have their Vitamin D concentration measured.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 2pt 12pt 1pt;"><span class="font1">NICE CG62 Antenatal care<sup>11 </sup>suggests that up to 1000IU daily is considered the maximum safe dose.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 2pt 12pt 1pt;"><span class="font1">Ensure Vitamin D concentrations remain above 50nmol/L throughout the year</span></p>

<p style="background-color:#FFFFFF;padding:12pt 2pt 0pt 1pt;"><span class="font1">A recent letter was sent to all healthcare professionals from the Chief Medical officer (3/2/12) offering advice on Vitamin D supplements further information can be found via</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;"><a href="http://www.nelm.nhs.uk/en/NeLM-">http://www.nelm.nhs.uk/en/NeLM-</a></span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;">Area/News/2012—</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;">February/16/Products-in-UK-that-</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;">enable-adherence-to-CMO-</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;">advice-on-Vitamin-D-</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;">supplementation/</span></p></td>

<td valign="top" width="43%">

<p style="background-color:#FFFFFF;padding:0pt 3pt 12pt 1pt;"><span class="font1">All women should continue with Vitamin D supplementation throughout pregnancy and breastfeeding.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 23pt 12pt 1pt;"><span class="font1">All women diagnosed with Vitamin D deficiency should continue treatment/maintenance whilst breast feeding.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 3pt 12pt 1pt;"><span class="font1">If deficient check Vitamin D concentration at 6 months post delivery. Consider lifelong maintenance.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 23pt 0pt 1pt;"><span class="font1">Advise all women about Healthy Start vitamins preconception and during pregnancy</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 21pt 60pt;"><span class="font0">10</span></p>

<p style="background-color:#FFFFFF;padding:21pt 23pt 12pt 1pt;"><span class="font1">If ineligible for Healthy Start advise 10 micrograms Vitamin D (400IU) daily -purchased over the counter. Vitamin supplements such as Pregnacare are available over the counter.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 3pt 12pt 1pt;"><span class="font1">Siblings under five years old should have maintenance with Healthy Start Vitamins (or Abidec/Dalvit) see Appendix 4</span></p>

<p style="background-color:#FFFFFF;padding:12pt 3pt 0pt 1pt;"><span class="font1">NB: Women at risk (Black Minority Ethnic (BME)/darker skin) will be tested routinely by Liverpool Women's NHS Foundation Trust and treatment advised as necessary.</span></p></td></tr></table><hr/>

<p style="background-color:#FFFFFF;"><span class="font1" style="font-weight:bold;">For advice re prevention and treatment of Vitamin D disorders in Children please refer to</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 169pt;"><span class="font1" style="font-weight:bold;">separate Alder Hey Guidance</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 18pt 22pt;"><a name="bookmark6"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">References:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:18pt 15pt 0pt 22pt;"><span class="font1">1. Sievenpiper J L, Mclntyre E A, Verrill M, Quinton R and Pearce SHS. Unrecognised severe Vitamin D deficiency. BMJ 2008; 336;1371-1374 doi:10.1136/bmj.39555.820394.BE</span></p>

<p style="background-color:#FFFFFF;padding:0pt 15pt 0pt 22pt;"><span class="font1">2. Pearce S, Cheetham D. Diagnosis and management of Vitamin D deficiency. BMJ 2010;340:65664 doi:101136/bmj/b5664</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 22pt;"><span class="font1">3. Holik FM. Vitamin D deficiency. NEJM 2007; 357; 1371-1374</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 15pt 0pt 22pt;"><span class="font1">4. Dietary Supplements. Vitamin D monograph. London: Pharmaceutical Press. Accessed via <a href="http://www.medicinescomplete.com">http://www.medicinescomplete.com</a> on 16/06/10 and Holick M, Vitamin D. importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. American Journal of Clinical Nutrition 2004; 79: 362-371.</span></p>

<p style="background-color:#FFFFFF;padding:0pt 15pt 0pt 22pt;"><span class="font1">5. Cancer Research UK, National Osteoporosis Society, British Association of Dermatologists, Diabetes UK. Consensus Vitamin D position statement: 2010. Online: Available at <a href="http://www.nelm.nhs.uk/en/NeLM-Area/News/2010%e2%80%94December/17/Consensus-Vitamin-D-">http://www.nelm.nhs.uk/en/NeLM-Area/News/2010—December/17/Consensus-Vitamin-D-</a>position-statement/</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 15pt 0pt 22pt;"><span class="font1">6. Dietary Supplements. Vitamin D monograph. London: Pharmaceutical Press. Accessed via <a href="http://www.medicinescomplete.com">http://www.medicinescomplete.com</a> on 16/06/10</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 20pt 0pt 22pt;"><span class="font1">7. M Z Mughal, H Salama, T Greenaway, I Laing, E B Mawer. Florid rickets associated with prolonged breast feeding without vitamin D supplementation. BMJ 1999; 318 2 JANUARY 1999 <a href="http://www.bmj.com">www.bmj.com</a> 3</span></p>

<p style="background-color:#FFFFFF;padding:0pt 15pt 0pt 22pt;"><span class="font1">8. Sharma S, Khan N, Khadri A, Julies P, Gnanasambandam S, Saroey S, Jacobs B, Beski S, Coren M, Alexander S .Vitamin D in pregnancy-time for action: a paediatric audit. BJOG 2009; 116 (12) 1678-1682 . Online: DOI: 10.1111/j.1471-0528.2009.02285</span></p>

<p style="background-color:#FFFFFF;padding:0pt 43pt 0pt 22pt;"><span class="font1">9. Committee on Medical Aspects (COMA) of Food and Nutrition Policy (DH 1991, 2004, </span><span class="font1" style="color:#0000FF;">2002). Available at </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.doh.gov.uk">www.doh.gov.uk</a></span></p>

<p style="background-color:#FFFFFF;padding:0pt 15pt 0pt 22pt;"><span class="font1">10. NICE. NICE public health guidance 11: Improving the nutrition of pregnant and breastfeeding mothers and children in low-income households. NICE (2008) (updated July </span><span class="font1" style="color:#0000FF;">2011) Available at </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.nice.org.uk">www.nice.org.uk</a></span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 22pt;"><span class="font1">11. NICE CG62 - Antenatal care </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.nice.org.uk/CG62">www.nice.org.uk/CG62</a></span></p>

<p style="background-color:#FFFFFF;padding:0pt 53pt 0pt 22pt;"><span class="font1">12. East &amp; South east England Specialist Pharmacy services - Vitamin d deficiency and insufficiency November 2011</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 15pt 0pt 22pt;"><span class="font1">13. Dietary Supplements. Vitamin D monograph. London: Pharmaceutical Press. Accessed via </span><span class="font1" style="text-decoration:underline;"><a href="http://www.medicinescomplete.com">www.medicinescomplete.com</span><span class="font1"></a> on 16/06/10</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 15pt 0pt;"><a name="bookmark7"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Appendix 1 - Conditions outside the scope of this guidance</span></p>

<p style="background-color:#FFFFFF;padding:15pt 17pt 0pt 0pt;"><a name="bookmark8"></a><span class="font1" style="font-weight:bold;">The following are outside the scope of this guideance. See condition related guidelines for further information. Referral to specialist may be appropriate.</span></p>

<table cellpadding="28pt">

<tr>

<td valign="top" width="33%">

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 18pt;"><a name="bookmark9"></a><span class="font1">• Renal disease<a name="footnote1"></a><sup><a href="#bookmark10">1</a></sup></span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 18pt;"><a name="bookmark11"></a><span class="font1">• Osteoporosis **</span></p>

<p style="background-color:#FFFFFF;padding:0pt 3pt 0pt 18pt;"><span class="font1">• Secondary prevention post fractures</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 3pt 0pt 18pt;"><span class="font1">• Failure to respond to treatment after 3 months</span></p>

<p style="background-color:#FFFFFF;padding:0pt 3pt 0pt 18pt;"><span class="font1">• All children under 1 year</span></p>

<p style="background-color:#FFFFFF;padding:0pt 29pt 0pt 18pt;"><span class="font1">• Atypical biochemistry</span></p></td>

<td valign="top" width="33%">

<p style="background-color:#FFFFFF;padding:0pt 2pt 0pt 18pt;"><span class="font1">• Atypical clinical manifestations or biochemistry</span></p>

<p style="background-color:#FFFFFF;padding:0pt 2pt 0pt 18pt;"><span class="font1">• Deficiency due to malabsorption</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><span class="font1">• Focal bone pain</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><span class="font1">• Liver disease</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><a name="bookmark12"></a><span class="font1">• Lymphoma</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><span class="font1">• Metastatic cancer</span></p>

<p style="background-color:#FFFFFF;padding:0pt 34pt 0pt 18pt;"><span class="font1">• Parathyroid disorders</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><span class="font1">• Renal stones</span></p></td>

<td valign="top" width="33%">

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 3pt 0pt;"><span class="font1">• Sarcoidosis</span></p>

<p style="background-color:#FFFFFF;padding:3pt 2pt 0pt 18pt;"><span class="font1">• Short stature and Skeletal deformity</span></p>

<p style="background-color:#FFFFFF;text-align:justify;"><span class="font1">• Tuberculosis</span></p>

<p style="background-color:#FFFFFF;padding:0pt 28pt 0pt 18pt;"><span class="font1">• Unexplained deficiency</span></p>

<p style="background-color:#FFFFFF;padding:0pt 28pt 0pt 18pt;"><span class="font1">• Unexplained weight loss</span></p></td></tr></table><hr/>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 15pt 1pt;"><a name="bookmark13"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">*Renal Disease - eGFR less than 30mL/minute/1.73m<sup>2</sup></span></p>

<p style="background-color:#FFFFFF;padding:15pt 11pt 12pt 1pt;"><span class="font1">NICE clinical guideline CG73 on chronic kidney disease, published in 2008, advises on which vitamin D preparations should be used and when, according to the stage of renal impairment.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 12pt 1pt;"><span class="font1">NICE CG73 Chronic kidney disease. NICE Guideline. 2008. Available at </span><span class="font1" style="text-decoration:underline;color:#800080;"><a href="http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdf">http://www.nice.org.uk/nicemedia/live/12069/42117/42117.pdf</a></span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 12pt 1pt;"><span class="font1">The information has been summarized in a NICE pathway see </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://pathways.nice.org.uk/pathways/chronic-kidney-disease">http://pathways.nice.org.uk/pathways/chronic-kidney-disease</a></span></p>

<p style="background-color:#FFFFFF;padding:12pt 0pt 15pt 1pt;"><a name="bookmark14"></a><span class="font1" style="font-weight:bold;">** </span><span class="font1" style="font-weight:bold;text-decoration:underline;">Osteoporosis and Falls</span></p>

<p style="background-color:#FFFFFF;padding:15pt 11pt 12pt 1pt;"><span class="font1">See NICE Technology Appraisals TA160 and TA161 for further information re Osteoporosis </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.nice.org.uk">www.nice.org.uk</a></span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 0pt 1pt;"><span class="font1">Local osteoporosis guideline currently in development - </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.northmerseyammc.nhs.uk/">http://www.northmerseyammc.nhs.uk/</a> </span><span class="font1">Alternatively refer to your local Medicines Management Team for further advice</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 12pt 1pt;"><a name="bookmark15"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Appendix 2 - Prescribing Guidance</span></p>

<p style="background-color:#FFFFFF;padding:12pt 13pt 0pt 1pt;"><span class="font1">There are numerous issues surrounding Vitamin D products and availability and the Department of Health are aware of the need for a licensed product and are in discussion with the Medicines and Healthcare products Regulatory Agency (MHRA) and pharmaceutical industry.</span></p>

<p style="background-color:#FFFFFF;padding:0pt 13pt 0pt 1pt;"><span class="font1">Although licensed products should be used where available in some circumstances unlicensed or special products may be suitable following appropriate consideration of the increased risks and substantial costs of such medicines.<sup>12 </span><span class="font1" style="font-weight:bold;"></sup>For further information please see</span></p>

<p style="background-color:#FFFFFF;padding:0pt 13pt 0pt 1pt;"><a name="bookmark16"></a><span class="font1" style="font-weight:bold;text-decoration:underline;color:#0000FF;"><a href="http://www.nelm.nhs.uk/en/NeLM-Area/Other-Lib-Updates/Drug-Discontinuation-And-">http://www.nelm.nhs.uk/en/NeLM-Area/Other-Lib-Updates/Drug-Discontinuation-And-</a>Shortage/Vitamin-D-product-availability/</span></p>

<p style="background-color:#FFFFFF;padding:0pt 13pt 6pt 1pt;"><a name="bookmark17"></a><span class="font1" style="font-weight:bold;text-decoration:underline;color:#0000FF;"><a href="http://www.nelm.nhs.uk/en/NeLM-Area/Other-Lib-Updates/Drug-Discontinuation-And-">http://www.nelm.nhs.uk/en/NeLM-Area/Other-Lib-Updates/Drug-Discontinuation-And-</a>Shortage/Vitamin-D---Available--products-for-DOH-recommendations/</span></p>

<p style="background-color:#FFFFFF;padding:6pt 0pt 0pt 1pt;"><a name="bookmark18"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Prescribing Options:</span></p>

<p style="background-color:#FFFFFF;padding:0pt 13pt 6pt 37pt;"><span class="font1">•</span><span class="font1" style="font-weight:bold;"> Pro D3 Colecalciferol 20,000IU capsules -</span><span class="font1" style="font-style:italic;"> This is not a licensed medicine as it is classed as a food/vitamin product.</span><span class="font1"> Capsules and liquid are available in various strengths ranging from 400IU to 30,000IU. This product is suitable for patients with nut allergies is gelatin free, suitable for vegetarians and halal diets. The 20,000IU capsules are available at a set price of £19.99 per 30 capsules and are not classed as a 'special' so there should be no price variation. Pro-D3 is available directly from the manufacturer, AAH and Phoenix wholesalers so there should not be any supply problems in primary care. Please prescribe on acute prescriptions. A liquid preparation and other strengths of Vitamin D are also available. Further information can be found at </span><span class="font1" style="text-decoration:underline;"><a href="http://www.prod3.co.uk/">http://www.prod3.co.uk/</span><span class="font1" style="font-weight:bold;font-style:italic;"></a> Nutritional supplements are generally subject to food safety labelling legislation and whilst this excludes them from a formal licensing process they may be considered a potentially useful option in some circumstances following consideration of the risks<sup>12</sup>.</span></p>

<p style="background-color:#FFFFFF;padding:6pt 13pt 0pt 37pt;"><span class="font1" style="font-weight:bold;">• Dekristol 20,000IU capsules -</span><span class="font1" style="font-style:italic;"> Unlicensed special import from EU (price variable) specify &quot;order from IDIS, Martindale or Pharmarama&quot; on the prescription. Prescribe on acute prescriptions. Pack size available 50capsules. This product is licensed in Germany and manufactured by MIBE pharmaceuticals</span></p>

<p style="background-color:#FFFFFF;padding:0pt 32pt 0pt 37pt;"><span class="font1">NB Dekristol contains gelatin and is NOT suitable for nut allergies - for more information please see MHRA warning</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 6pt 37pt;"><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON140797">http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON140797</a></span></p>

<p style="background-color:#FFFFFF;padding:6pt 32pt 0pt 37pt;"><span class="font1">•</span><span class="font1" style="font-weight:bold;"> Fultium-D3 800IU capsules</span><span class="font1"> - Newly licensed product available. Contains peanut oil. 25 x 800IU caps equivalent to 1x 20,000IU. Not recommended for use in under 12years. Manufacturers licensed dose:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 6pt 73pt;"><span class="font1">• Deficiency: 1-4caps daily (800-3200IU) for 12 weeks.</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:6pt 0pt 12pt 73pt;"><span class="font1">• Insuffiency / Maintenance / Prevention: 1-2caps (800-1600IU) daily.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 50pt 0pt 37pt;"><a name="bookmark19"></a><span class="font1">•</span><span class="font1" style="font-weight:bold;"> Ergocalciferol 300,000IU intra-muscular injection</span><span class="font1"> - once or twice a year (variable availability)</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 15pt 1pt;"><a name="bookmark20"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Appendix 3 - Alfacalcidol</span></p>

<p style="background-color:#FFFFFF;padding:15pt 54pt 12pt 1pt;"><span class="font1">Alfacalcidol is not considered appropriate for community use in Vitamin D deficiency unless advised by Renal or Clinical Blood Sciences (Clinical Chemistry) Specialists due to risk of hypercalcaemia</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 12pt 1pt;"><span class="font1">A recent signal alert from the National Patient Safety Alerts (NPSA) highlights the risks associated with alfacalcidol prescribing</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 0pt 1pt;"><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.nrls.npsa.nhs.uk/resources/?entryid45=132827">http://www.nrls.npsa.nhs.uk/resources/?entryid45=132827</a> </span><span class="font1" style="font-weight:bold;text-decoration:underline;">Risks of hypercalcaemia</span></p>

<p style="background-color:#FFFFFF;padding:0pt 11pt 12pt 1pt;"><span class="font1">Alfacalcidol and excessive intake of products containing Vitamin D can lead to hypercalcaemia and its associated effects.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 0pt 0pt 1pt;"><span class="font1">Symptoms of toxicity include:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark21"></a><span class="font1">• apathy</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark22"></a><span class="font1">• anorexia</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><span class="font1">• constipation</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark23"></a><span class="font1">• diarrhoea</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark24"></a><span class="font1">• dry mouth</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark25"></a><span class="font1">• fatigue</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><a name="bookmark26"></a><span class="font1">• headache</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><span class="font1">• nausea &amp; vomiting</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 12pt 21pt;"><span class="font1">• thirst and weakness</span></p>

<p style="background-color:#FFFFFF;padding:12pt 0pt 0pt 1pt;"><span class="font1">Toxicity can lead to:</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><span class="font1">• calcification of soft tissues and bone pain,</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><span class="font1">• cardiac arrhythmias,</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 21pt;"><span class="font1">• hypertension,</span></p>

<p style="background-color:#FFFFFF;padding:0pt 33pt 0pt 37pt;"><span class="font1">• kidney damage (increased urinary frequency, decreased urinary concentration; nocturia, proteinuria),</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 12pt 21pt;"><span class="font1">• psychosis (rarely) and weight loss.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 24pt 1pt;"><span class="font1">If toxicity is suspected, vitamin D must be withdrawn and serum calcium and renal function checked urgently, since emergency inpatient care with rehydration is usually indicated<sup>13</sup></span></p>

<p style="background-color:#FFFFFF;padding:24pt 11pt 0pt 1pt;"><span class="font1">Patients receiving treatment with alfacalcidol should have plasma-calcium levels initially checked once or twice weekly as per product SPC when initiating treatment with alphacalcidol and whenever nausea and vomiting or other symptoms of toxicity occur during treatment. Once stabilised plasma calcium levels should be checked at intervals as per BNF 62.</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 15pt 1pt;"><a name="bookmark27"></a><span class="font1" style="font-weight:bold;text-decoration:underline;">Appendix 4 - Healthy Start Scheme</span></p>

<p style="background-color:#FFFFFF;padding:15pt 0pt 15pt 1pt;"><a name="bookmark28"></a><span class="font1" style="font-weight:bold;">What is the Healthy Start Scheme?</span></p>

<p style="background-color:#FFFFFF;padding:15pt 11pt 12pt 1pt;"><span class="font1">The Healthy Start Scheme is a statutory scheme which started in 2006 and replaced the Welfare Food Scheme. The scheme aims to improve the health of pregnant women and families on benefits or low incomes. The scheme provides a nutritional safety net, encourages breastfeeding / healthy eating and is used as a public health tool.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 0pt 15pt 1pt;"><a name="bookmark29"></a><span class="font1" style="font-weight:bold;">How do you sign women / children up?</span></p>

<p style="background-color:#FFFFFF;padding:15pt 11pt 12pt 1pt;"><span class="font1">The application forms need to be signed by GPs, midwives, health visitors or other registered nurses. Health professionals are not required to check eligibility they just need to sign the application form. Any subsequent changes in personal circumstances must be reported by the beneficiary not the health professional.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 12pt 1pt;"><span class="font1">The application forms (HS01) can be ordered via </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.orderline.dh.gov.uk">www.orderline.dh.gov.uk</span><span class="font1" style="color:#0000FF;"></a> </span><span class="font1">or by calling 0300 123 1002. The forms should be available in health and children centres.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 0pt 30pt 1pt;"><span class="font1" style="font-style:italic;">N.B. Re-application for healthy start vitamins is required following the birth of child.</span></p>

<p style="background-color:#FFFFFF;padding:30pt 0pt 15pt 1pt;"><a name="bookmark30"></a><span class="font1" style="font-weight:bold;">What are the beneficiaries entitled to?</span></p>

<p style="background-color:#FFFFFF;padding:15pt 11pt 12pt 1pt;"><span class="font1">Beneficiaries are sent vouchers that can be exchanged for cow's milk, fresh / frozen fruit, vegetables and infant formula.</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:12pt 18pt 12pt 1pt;"><span class="font1">Beneficiaries are also sent vitamin coupons which can be exchanged for vitamin supplements for pregnant women, new mothers and children up to 4 years. Women's tablets contain Vitamin C, D and folic acid and Children's drops contain Vitamin A, C and D.</span></p>

<p style="background-color:#FFFFFF;padding:12pt 11pt 0pt 1pt;"><span class="font1">N.B. Healthy Start Vitamins may be universally available in some parts of the Mersey Cluster </span><span class="font1" style="color:#0000FF;">Further information - </span><span class="font1" style="text-decoration:underline;color:#0000FF;"><a href="http://www.healthystart.nhs.uk">www.healthystart.nhs.uk</a></span></p>

<p style="background-color:#FFFFFF;"><span class="font0">Mersey Cluster Guidance Final version Updated February 20121</span></p>

<p style="background-color:#FFFFFF;"><span class="font0">Page 11 of 11</span></p>

<p style="background-color:#FFFFFF;"><span class="font0">Prepared by Liverpool Medicines Management Team, Dr Katy Gardner and Liverpool Vitamin D Group</span></p>

<p><a name="bookmark10"><sup><a href="#footnote1">1</a></sup></a></p>

<p style="background-color:#FFFFFF;padding:0pt 51pt 0pt 36pt;"><span class="font1"></span><span class="font1" style="font-weight:bold;"> Over the counter products</span><span class="font1"> - Patients can be directed to purchase over the counter products. A dose of 800IU per day should be recommended for</span><span class="font1" style="font-weight:bold;"> maintenance and prevention regimes.</span><span class="font1"> Brands of Vitamin D tablets include:</span></p>

<p style="background-color:#FFFFFF;padding:0pt 51pt 0pt 73pt;"><span class="font1">• Solgar® (Vitamin D3 - Colecalciferol) vegetarian capsules available in various strengths (suitable for nut allergy sufferers),</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 55pt;"><span class="font1">• Pro D3 products available in a range of strengths from 400IU (10mcg) to 30,000IU,</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 55pt;"><span class="font1">• Boots and Holland &amp; Barrett also offer a range of Vitamin D products.</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 44pt;"><span class="font0" style="font-weight:bold;">Information correct as of 21<sup>st</sup> February 2012 - product availability and licensed indications change frequently, please contact</span></p>

<p style="background-color:#FFFFFF;padding:0pt 0pt 0pt 169pt;"><span class="font0" style="font-weight:bold;">your Medicines Management Team if you have any queries</span></p>

<p style="background-color:#FFFFFF;text-align:justify;padding:0pt 0pt 0pt 36pt;"><span class="font0">Mersey Cluster Guidance Final version Updated February 20121</span></p>

<p style="background-color:#FFFFFF;text-align:center;padding:0pt 0pt 0pt 11pt;"><span class="font0">Page 9 of 11</span></p>

<p style="background-color:#FFFFFF;text-align:center;padding:0pt 0pt 0pt 11pt;"><span class="font0">Prepared by Liverpool Medicines Management Team, Dr Katy Gardner and Liverpool Vitamin D Group</span></p>

<table width="100%"><tr></tr>

</table>

</body>

</html>